瘤微环境特定的化学内部化用于转移性乳腺癌增强基因治疗
Yun Zhou1, Mian Yu1, Changjun Tie2
1School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen 518107, China.
Research (Washington, D.C.)
|April 15, 2024
概括
这项研究引入了一种新型的基因传递系统,通过利用瘤微环境特异反应来克服生物障碍,提高治疗效率. 开发的系统在抑制乳腺癌生长和转移方面显著有前途.
科学领域:
- 生物医学工程 生物医学工程
- 基因治疗 基因治疗
- 纳米技术纳米技术
背景情况:
- 基因疗法面临的挑战是细胞外和细胞内障碍,限制治疗疗效.
- 光化学内化 (PCI) 提供了内/溶酶体的逃生,但由于光线的透性较差而受到影响.
- 开发有效的基因传递系统需要克服这些障碍,以改善治疗结果.
研究的目的:
- 开发一种针对瘤微环境的基因传递系统,以提高治疗效率.
- 克服现有的基因传递方法的局限性,包括酶降解和内/溶酶体隔离.
- 创建一个利用现场生成的活性氧物种 (ROS) 来改善基因传输的系统.
主要方法:
- 工程设计的G@MMSNs-P纳米粒子装有抗Twist siRNA.
- 利用涉及葡萄糖氧化酶 (GOx) 和Mn2+的级联催化反应在瘤微环境内在位生成ROS.
- 研究了酶保护,内分/淋巴体逃逸,瘤特异性生物降解和T1加权MR成像能力.
主要成果:
- 证明了有效的酶保护和货物基因复合体的成功内/溶酶逃脱.
- 实现了抗Twist siRNA装载的G@MMSNs-P.的瘤特异生物降解.
- 呈现出优异的T1加权MR成像特性和显著抑制乳腺癌生长和肺转移.
结论:
- 开发的基因传递系统通过瘤微环境特定的ROS生成,有效地克服生物障碍.
- G@MMSNs-P纳米颗粒显示出高级乳腺癌治疗的潜力,结合了基因传递,成像和治疗效果.
- 这种方法在克服癌症治疗的基因传递挑战方面取得了重大进展.
更多相关视频
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
16.7K
09:42Assessing Tumor Microenvironment of Metastasis Doorway-Mediated Vascular Permeability Associated with Cancer Cell Dissemination using Intravital Imaging and Fixed Tissue Analysis
Published on: June 26, 2019
8.8K
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Tumor Immunotherapy
522
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
522
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
